| Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis AC Codo, GG Davanzo, L de Brito Monteiro, GF de Souza, SP Muraro, ... Cell metabolism 32 (3), 437-446. e5, 2020 | 865 | 2020 |
| Safety and outcomes associated with the pharmacological inhibition of the kinin–kallikrein system in severe COVID-19 E Mansour, AC Palma, RG Ulaf, LC Ribeiro, AF Bernardes, TA Nunes, ... Viruses 13 (2), 309, 2021 | 44 | 2021 |
| SARS-CoV-2 uses CD4 to infect T helper lymphocytes GG Davanzo, AC Codo, NS Brunetti, VO Boldrini, TL Knittel, LB Monterio, ... | 43* | 2020 |
| Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial E Mansour, FF Bueno, JC de Lima-Júnior, A Palma, M Monfort-Pires, ... Trials 22, 1-13, 2021 | 28 | 2021 |
| Plasma angiotensin II is increased in critical coronavirus disease 2019 RL Camargo, B Bombassaro, M Monfort-Pires, E Mansour, AC Palma, ... Frontiers in Cardiovascular Medicine 9, 847809, 2022 | 26 | 2022 |
| Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19 MW Henderson, F Lima, CRP Moraes, A Ilich, SC Huber, MS Barbosa, ... Blood Advances 6 (11), 3367-3377, 2022 | 23 | 2022 |
| Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19–A proof-of-concept study E Mansour, AC Palma, RG Ulaf, LC Ribeiro, AF Bernardes, TA Nunes, ... MedRxiv, 2020.08. 11.20167353, 2020 | 6 | 2020 |
| Association of Ang/Tie2 pathway mediators with endothelial barrier integrity and disease severity in COVID-19 CRP Moraes, IT Borba-Junior, F De Lima, JRA Silva, B Bombassaro, ... Frontiers in physiology 14, 1113968, 2023 | 4 | 2023 |
| Circulating levels of Ang/Tie2 and VEGF-a pathway mediators are associated with clinical severity, endothelial barrier disruption and coagulation activation in COVID-19 CRP de Moraes, IT de Borba Junior, F de Lima, MS Barbosa, SC Huber, ... Blood 138, 2073, 2021 | 4 | 2021 |
| Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin–Kallikrein System in Severe COVID-19. Viruses 2021, 13, 309 E Mansour, AC Palma, RG Ulaf, LC Ribeiro, AF Bernardes, TA Nunes, ... s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021 | 4 | 2021 |
| Association of heme-oxygenase 1, hemopexin, and heme levels with markers of disease severity in COVID-19 F de Lima, CRP Moraes, MS Barbosa, B Bombassaro, AC Palma, ... Experimental Biology and Medicine 248 (4), 309-316, 2023 | 3 | 2023 |
| Association of the angiopoietin/TIE2 and VEGF-a pathways with clinical and laboratory markers of disease severity incovid-19 CRP Moraes, F Lima, IT Borba Junior, MS Barbosa, LC Ribeiro, ... Research and Practice in Thrombosis and Haemostasis, 2021 | 1 | 2021 |
| Podoplanin and CLEC-2 levels in patients with COVID-19 IT Borba-Junior, F Lima, D Sidarta-Oliveira, CRP Moraes, ... Research and Practice in Thrombosis and Haemostasis 7 (5), 100282, 2023 | | 2023 |
| The challenge to include adolescent girls and young women in maternal and reproductive health research RE Soeiro, RT Souza, RM Nakamura, SF Bento, FG Surita, JG Cecatti, ... International journal of gynaecology and obstetrics: the official organ of …, 2023 | | 2023 |
| Brief Communication Highlight article F de Lima, CRP Moraes, MS Barbosa, B Bombassaro, AC Palma, ... Experimental Biology and Medicine 248, 309-316, 2023 | | 2023 |
| Circulating levels of podoplanin and CLEC-2 in COVID-19: An exploratory study I Borba, F Lima, C Peachazepi De Moraes, M Silva Barbosa, D Oliveira, ... Research and Practice in Thrombosis and Haemostasis Conference, 2022 | | 2022 |
| Association of heme/hemopexin/heme-oxygenase 1 pathway with clinical and laboratory markers of severity in Covid-19 F Lima, C Peachazepi De Moraes, M Silva Barbosa, B Bombassaro, ... Research and Practice in Thrombosis and Haemostasis Conference, 2022 | | 2022 |
| Contact system and intrinsic pathway are activated and associated with clinical and laboratory outcomes in COVID-19patients MW Henderson, F Lima, CRP Moraes, A Ilich, S Huber, SAL Montalvao, ... Research and Practice in Thrombosis and Haemostasis, 2021 | | 2021 |
| Circulating levels of platelet, endothelial and red blood cell microvesicles in COVID-19: Association with biomarkers of coagulation, fibrinolysis and angiogenesis MS Barbosa, F Lima, CRP Moraes, IP Santos, IT Borba Junior, SC Huber, ... Research and Practice in Thrombosis and Haemostasis, 2021 | | 2021 |
| Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19 A proof-of-concept study (preprint) E Mansour, AC Palma, RG Ulaf, LC Ribeiro, AF Bernardes, TA Nunes, ... | | 2020 |
